跳至主要内容
临床试验/NCT04173104
NCT04173104已完成早期 1 期

Pilot Study of [18F]PARPi PET/MR Imaging in Patients With New and/or Suspected Recurrent Brain Tumors

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2019年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
5
试验地点
1
主要终点
SUVmax measurements

研究概览

简要总结

This study is to collect data about how 18FPARPi can be used together with PET/positron emission tomography and MRI/magnetic resonance imaging scans to take pictures of brain cancer

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with new or suspected recurrent brain tumors (including suspected recurrent brain tumors showing growth from any preceding scan)
  • Age >/= 18 years
  • Minimum at least one brain lesion size >/= 1.5cm diameter
  • Scheduled to undergo treatment at MSK
  • Willingness to sign informed consent
  • Able to receive intravenous gadolinium contrast per MSK Department of Radiology guidelines

排除标准

  • Any contraindication to 3T MRI (PET/MR scanner is 4.0 Tesla)
  • Pregnancy or breast-feeding women

研究组 & 干预措施

Participants with Brain Cancer

Experimental

Participants with new or suspected recurrent brain tumors

干预措施: PET/MR with [18F]PARPi (Diagnostic Test)

Participants with Brain Cancer

Experimental

Participants with new or suspected recurrent brain tumors

干预措施: [18F]PARPi (Drug)

结局指标

主要结局

SUVmax measurements

时间窗: Up to 24 weeks

\[18F\]PARPi updtake in lesions will be quantified by standard SUVmax measurements from PET/MR scans

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

相关资讯